Hjem › Lupus nefritis › Ohio
Lupus nefritis kliniske forsøg i Ohio
7 studier for Lupus nefritis søger deltagere på steder i Ohio.
Byer i Ohio
Officiel studietekst (engelsk)
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
- Cleveland Clinic Foundation, Cleveland
RekruttererFase 2
Alder 18 til 100 · Alle køn · Opdateret 1. okt. 2026 · NCT05268289The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study
- Akron Children's Hospital, Akron
- Cincinnati Children's Hospital Medical Center, Cincinnati
- University Hospitals Cleveland Medical Center, Cleveland
- og 1 flere
RekruttererFase 2
Alder 8 til 20 · Alle køn · Opdateret 14. sep. 2026 · NCT05538208A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants
- Cincinnati Childrens Hospital, Cincinnati
RekruttererFase 2
Alder 5 til 17 · Alle køn · Opdateret 3. sep. 2026 · NCT05039619Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN
- GSK Investigational Site, Columbus
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 2. jul. 2026 · NCT06527872A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- MetroHealth, Cleveland
RekruttererFase 1
Alder 12 til 70 · Alle køn · Opdateret 22. maj 2026 · NCT06308978Lupus Landmark Study: A Prospective Registry and Biorepository
- The MetroHealth System, Cleveland
RekruttererObservationsstudie
Alder 18 til 110 · Alle køn · Opdateret 15. apr. 2026 · NCT05934149Safety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of Proliferative Forms of Lupus Glomerulopathy: Synergy Trial
- Nephrology Clinical Trials Unit The Ohio State University Wexner Medical Center, Columbus
RekruttererFase 4
Alder 18 til 80 · Alle køn · Opdateret 6. nov. 2025 · NCT07225387Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.